Stocks · News reference
Jasper Therapeutics Appoints Jeet Mahal As Interim Principal Financial Officer Effective October 9, 2026; Herb Cross Resigns As CFO Effective October 9, 2026
On September 23, 2026, Herb Cross submitted his resignation, effective as of October 9, 2026, as Chief Financial Officer, Principal Financial Officer, Principal Accounting Officer and Corporate Secretary of Jasper
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
8-K filing — Jasper Therapeutics, Inc. (JSPR)
Filed: 2026-10-15 AccNo: 0001213900-26-109587 Size: 244 KB Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits
William Blair Reinstates Outperform on Jasper Therapeutics
William Blair analyst Matt Phipps reinstates Jasper Therapeutics (NASDAQ:JSPR) with a Outperform.
Jasper Therapeutics Announces $0.324/Warrant Cash Tender Offer For All 12,345,707 Outstanding Warrants, Expiring November 6